Legend Biotech Corp - ADR

NASDAQ:LEGN   4:00:00 PM EDT
53.96
+2.97 (+5.82%)
7:40:14 PM EDT: $54.22 +0.26 (+0.48%)
Products

Legend Biotech Announces FDA Clearance Of Ind Application For Lb2102 In Extensive Stage Small Cell Lung Cancer

Published: 11/21/2022 14:53 GMT
Legend Biotech Corp - ADR (LEGN) - Legend Biotech Announces FDA Clearance of Ind Application for Lb2102 in Extensive Stage Small Cell Lung Cancer.